Sponsor study identifier
observational
150
1 country
1
Study Start
May 30, 2021
Actual (reported)Primary Completion
August 23, 2023
Actual (reported)Study Completion
November 1, 2023
Actual (reported)Rivermead Mobility Index (RMI) is an internationally used tool to assess mobility for both research and clinical practice in stroke survivors. This tool had previously been translated into many languages. However, the Urdu version of RMI is not available yet. The purpose of this study was to translate the RMI into Urdu (RMI-U) and to evaluate the validity and reliability of the translated version among Urdu-speaking stroke survivors in Pakistan. A standardized stepwise forward-backward translation procedure following international guidelines, was used to translate RMI into Urdu. The RMI-U pre-final version underwent thorough psychometric testing. Content validity was evaluated by measuring content validity indices (CVIs). The test-retest reliability of final version was then evaluated among 150 stroke survivors after a one-week interval. Furthermore, internal consistency was measured by Cronbach's alpha and construct validity by exploring factor analysis using the principle of component extraction and a Varimax rotation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 1, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 30, 2021
Actual (reported)August 23, 2023
Actual (reported)November 1, 2023
Actual (reported)July 15, 2024
Actual (reported)July 25, 2024
Actual (reported)Rivermead Mobility Index
mobility assessment
2nd day
Whereas those with cognitive impairment, Broca aphasia Wernicke s aphasia or with other neurological disorder e.g. previous cranial traumatic injuries tumors
Binash Afzal
Lahore, Punjab Province, 54000, Pakistan
Rossier P, Wade DT. Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. Arch Phys Med Rehabil. 2001 Jan;82(1):9-13. doi: 10.1053/apmr.2001.9396.
Franchignoni F, Tesio L, Benevolo E, Ottonello M. Psychometric properties of the Rivermead Mobility Index in Italian stroke rehabilitation inpatients. Clin Rehabil. 2003 May;17(3):273-82. doi: 10.1191/0269215503cr608oa.
Binash Afzal, phD*
Riphah International University
150 participants (actual enrollment reported by the registry).
First Submitted
July 15, 2024
First Posted
July 25, 2024
Study Start
May 30, 2021
Actual (reported)Task Oriented Mirror Therapy for Upper Limb Motor Function in Stroke Patient
Contact the study team to confirm eligibility.
Pavan K, da Cruz LC, Nunes MF, Menezes LG, Marangoni BE. Cross-cultural adaptation and validation of the Rivermead Mobility Index in stroke patients within the brazilian cultural and language context. Arq Neuropsiquiatr. 2010 Feb;68(1):52-5. doi: 10.1590/s0004-282x2010000100012.
Roorda LD, Green J, De Kluis KR, Molenaar IW, Bagley P, Smith J, Geurts AC. Excellent cross-cultural validity, intra-test reliability and construct validity of the Dutch Rivermead Mobility Index in patients after stroke undergoing rehabilitation. J Rehabil Med. 2008 Oct;40(9):727-32. doi: 10.2340/16501977-0249.
Steen Krawcyk R, Hagell P, Sjodahl Hammarlund C. Danish translation and psychometric testing of the Rivermead Mobility Index. Acta Neurol Scand. 2013 Oct;128(4):e20-5. doi: 10.1111/ane.12144. Epub 2013 Jun 13.
Primary Completion
August 23, 2023
Actual (reported)Study Completion
November 1, 2023
Actual (reported)Last Updated
July 25, 2024
Record last verified: 2024-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: